Paul Peter Tak - 25 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Paul Peter Tak
Issuer symbol
CADL
Transactions as of
25 Jun 2025
Net transactions value
+$199,997
Form type
4
Filing time
26 Jun 2025, 08:30:12 UTC
Previous filing
20 Mar 2025
Next filing
28 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tak Paul Peter Chief Executive Officer, Director C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-In-Fact for Paul Peter Tak 26 Jun 2025 0001873905

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $199,997 +42,826 +19% $4.67 268,566 25 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.